fda-nod-for-the-first-drug-abilify-maintena-to-be-commercialized-by-the-otsuka-and-lundbeck-alliance

Otsuka schizophrenia relapse gets FDA nod

  • Japan
  • |
  • Regulatory
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Japan-based Otsuka Pharmaceutical and H Lundbeck have received US FDA approval for Abilify Maintena (aripiprazole) extended-release injectable suspension,... Read more

sartorius-stedim-biotech-and-aber-instruments-joins-hands-for-sensor-technology-used-in-biomass-measurement

Sartorius, Aber join hands for biomass sensors

  • Europe
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Sartorius Stedim Biotech (SSB) entered into a global sales and development partnership with Aber Instruments, a Welsh company for bioprocess and brewing... Read more

ge-healthcare-2012-cell-imaging-competition-winners-ms-jane-stout-ms-anushree-balachandran-and-mr-markus-posch

Cell pics by GE contest winners to light up Times Square...

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: GE Healthcare Life Sciences has chosen Ms Jane Stout (from the US), Ms Anushree Balachandran (from Australia) and Mr Markus Posch (from the UK) as winners... Read more

who-a-global-ageing-population-will-lead-to-increase-in-the-number-of-individuals-suffering-from-hearing-loss

WHO: 360 million people suffer from hearing loss

  • Europe
  • |
  • Analysis
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: The World Health Organization (WHO) has launched new global data on the prevalence of hearing loss, on the occasion of International Ear Care Day (celebrated... Read more

anika-withdraws-hyalograft-c-after-failing-to-address-objections-by-ema-committees

Anika withdraws Hyalograft application from EMA

  • Europe
  • |
  • Regulatory
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: European Medicines Agency (EMA) has pointed out that Anika Therapeutics has withdrawn its application for centralized marketing authorization for the... Read more

associate-professor-serge-rudaz-of-geneva-university-s-school-of-pharmaceutical-sciences-invented-a-low-cost-machine-that-can-detect-weakened-or-counterfeit-drugs

Geneva scientist builds low-cost fake drug detector

  • Europe
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Associate professor Serge Rudaz of Geneva University's School of Pharmaceutical Sciences has invented a low cost machine that can detect weakened or counterfeit... Read more

oecd-recommends-member-eu-governments-to-harmonize-their-clinical-trial-approval-processes

OECD: EU should harmonize trial regulations

  • Europe
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Increasingly complex and inconsistent clinical trial regulations are causing delays, raising costs and leading to a decline in the number of international... Read more

swedish-telecommunications-operator-telia-bags-usd2

Swedish firm to handle AstraZeneca's telecom

  • Europe
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Swedish telecommunications operator Telia won a contract from AstraZeneca to take over its telecom support operations, including staff. AstraZeneca is... Read more

dr-joerg-reinhardt-appointed-as-chairman-to-the-novartis-board-of-directors-effective-august-1-2013

Reinhardt is Novartis chairman after Vasella's exit

  • Europe
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Novartis has appointed Dr Joerg Reinhardt as chairman to the board of directors effective August 1, 2013, for duration of three years. This is following... Read more

Special Features

Survey Box

Chinese Bird Flu H5N7

Have Chinese scientists done the right thing by fusing human and avian flu strains to create new killer viruses?

Send this article by email

X